(Q37877415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

HER2 status in breast cancer: experience of a Spanish National Reference Centre (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Carlos Cano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Francisco Javier López

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Paloma Talavera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Inmaculada García-Peréz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Armando Blanco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ángel Concha

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

335-340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

Municipal distribution of breast cancer mortality among women in Spain.

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Molecular prognostic factors for breast cancer metastasis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

High prevalence of HER-2/neu overexpression in female breast cancer among an Iraqi population exposed to depleted uranium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0663-4

The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study

21 January 2018

1 reference

12 December 2020

Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis

1 reference

12 December 2020

Assessment of a new anti-HER2 monoclonal antibody, SV2-61gamma: a best concordance with HER2 FISH

1 reference

12 December 2020

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

1 reference

12 December 2020

10.1007/S12094-011-0663-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21596662%20AND%20SRC:MED&resulttype=core&format=json

release_hf736wjovfbwlhcortfukxrnna

1 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hf736wjovfbwlhcortfukxrnna

24 November 2022

mapped directly with Wikidata item

1 reference